866-274-4009 Contact Us

Center for Breakthrough Medicines’ Amiel Gross speaks with Vanguard

Thanks to Vanguard for featuring Center for Breakthrough Medicines’ very own VP, Head of Legal Amiel Gross in Mary Raitt Jordan’s engaging profile piece. The story discusses a wide range of topics, including CBM’s partnership with James M. Wilson and the Gene Therapy Program | University of Pennsylvania and SK Inc.’s equity investment in CBM, as well as Amiel’s professional career and his passion for the company’s groundbreaking CDMO and gene therapy services in the heart of Cellicon Valley.

Read full story

March 14, 2022